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Copyright © 2011 JCBN 2011 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. Liver steatosis is associated with organ dysfunction after hepatic
resection and transplantation which may be caused by hepatic
ischemia/reperfusion injury. The aim of the current study was to
determine the precise mechanism leading to hepatocyte apoptosis
after steatotic liver ischemia/reperfusion. Using a murine model of
partial hepatic ischemia for 90 min, we examined the levels and
pathway of apoptosis, and the peroxynitrite expression, serum
alanine aminotransferase levels, and liver histology 1 and 4 h
after reperfusion. In the steatotic liver, the peroxynitrite expres 
sion increased after ischemia/reperfusion. Significant hepatocyte
apoptosis in the steatotic liver was seen after reperfusion, caused
by upregulation of cleaved caspases 9 and 3, but not caspase 8.
Serum alanine aminotransferase levels were elevated and histo 
logical examination revealed severe liver injury in the steatotic
liver 4 h after reperfusion. In mice treated with aminoguanidine,
ischemia/reperfusion induced increases in serum alanine amino 
transferase levels and apoptosis were significantly reduced in
steatotic liver compared with mice treated with phosphate
buffered saline. Survival of mice with steatotic livers significantly
improved by treatment with aminoguanidine. Our data suggested
that the steatotic liver is vulnerable to hepatic ischemia/reperfu 
sion, leading to significant hepatocyte apoptosis by the mito 
chondrial permeability transition, and thereby resulting in organ
dysfunction.
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Introduction Recently, the number of patients with hepatic steatosis has
increased due to alcohol abuse and non-alcoholic fatty liver
disease (NAFLD).(1) There are several metabolic disorders involved
in the steatotic liver, including oxidative stress, susceptibility to
apoptosis, and dysfunction of the mitochondria.(2–4) Steatotis in the
liver is associated with postoperative complications after hepatic
resection and primary graft nonfunction after liver transplanta-
tion.(5–7) Furthermore, the current shortage of organ donors leads to
an increase in use of steatotic livers for liver transplantation.(8,9)
Steatohepatitis after neoadjuvant chemotherapy for hepatic
malignancies is another clinical concern for liver damage and
insufficiency of liver regeneration after hepatic resection.(10) For
these reasons, further investigation of the cause of liver dysfunc-
tion in the steatotic liver after hepatic resection and transplantation
is necessary.
One of the major causes of liver dysfunction/damage after
hepatic surgery for a steatotic liver is hepatic ischemia/reperfusion
injury. In experimental studies, hepatic ischemia/reperfusion
injury is caused by the ischemic stress itself, the production of
reactive oxygen species, inflammatory responses induced by
proinflammatory mediators, neutrophil-mediated proteases, micro-
circulatory disturbance, and apoptosis of hepatocytes.(11–13)
Nitric oxide (NO) is the metabolic product by NO synthase
(NOS). Three isoforms of NOS have been identified; endothelial
NOS (eNOS), neural NOS, and inducible NOS (iNOS). NO
derived from eNOS has protective effects through maintenance
of microcirculation, but NO derived from iNOS is harmful due
to production of hazardous reactive oxygen species, such as per-
oxynitrite.(14) Such hazardous reactive oxygen species may lead
to hepatocyte apoptosis which is considered to be an important
factor in hepatic ischemia/reperfusion injury.(15) There are two
main pathways leading to apoptosis. The type 1 (extrinstic)
signaling pathway results from a death signal caused by the
expression of tumor necrosis factor-alpha and Fas ligand.(16)
Tumor necrosis factor-alpha and Fas associated death domains
promote the binding of procaspase 8, and the subsequent
proteolytic activation of catalytic caspase 8. Caspase 8 is able to
activate procaspase 3, leading to apoptosis.(17) Conversely, the type
2 (intrinstic) signaling pathway is induced by the mitochondrial
permeability transition, leading to cytochrome c release.(17,18) The
cytochrome  c complex activates caspase 9 followed by the
cleavage and subsequent activation of caspase 3.(19) Apoptosis
requires adenosine triphosphate (ATP), and a switch from
apoptosis to necrosis occurs when cells are devoid of ATP.(20)
Although much is known regarding hepatic ischemia/reperfusion
injury in the normal liver, the cause of steatotic liver ischemia/
reperfusion injury has not been thoroughly elucidated. We hypo-
thesized that excessive peroxynitrite production associated with
iNOS expression leads to hepatocyte apoptosis, thus resulting in
hepatic ischemia/reperfusion injury in the steatotic liver. The
aim of the current study was to determine whether hepatocyte
apoptosis is augmented in the steatotic liver after ischemia/
reperfusion and to examine the production of peroxinitrite and the
possible involvement of apoptosis after hepatic ischemia/reperfu-
sion.
Materials and Methods
Male BKS.Cg-m/+Leprdb mice, genotype Leprdb/Leprdb (db/db
mouse, JAX MICE Tsukuba Charles River Laboratories Japan,
Inc., Tsukuba, Japan) weighing 37 to 42 g were used as the fatty
liver (FL) group and lean littermates weighing 22 to 25 g were
used as the wild type (WT) group. The mice were housed in a
controlled environment, exposed to a 12-h light/dark cycle, and
provided with commercial chow and water ad libitum. This project
was approved by the Chiba University Animal Care and Use
Committee and was in compliance with National Institutes of
Health guidelines.
Hepatic ischemia/reperfusion model and reagents. The
model of partial hepatic ischemia and reperfusion employed was
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prepared as described previously.(11) Briefly, mice were anesthetized
with sodium pentobarbital (60 mg/kg administered intraperitone-
ally). A midline laparotomy was performed and an atraumatic clip
was used to interrupt the arterial and the portal venous blood
supply to the left lateral and median lobes of the liver for 90 min.
Sham control mice underwent the same procedure but without
vascular occlusion. The mice were sacrificed prior to surgery
(baseline), 1 and 4 h after reperfusion, and liver tissue and blood
samples were taken for analysis (n = 6, respectively). In the iNOS
inhibition experiment, prior to partial ischemia, mice received
either 25 mg/kg of aminoguanidine (AG) in sterile phosphate
buffered saline (0.1 ml) or just the phosphate buffered saline
(0.1 ml) (Sigma Aldrich, St. Louis, MO). The doses were adopted
based on the study by Cottart et al.(21) Survival was examined up
to 8 h after reperfusion (n = 6, respectively).
Analysis of apoptosis and histological examination.
Liver tissue specimens were obtained, and sections of formalin-
fixed paraffin-embedded liver samples were stained with hema-
toxylin-eosin to assess the degree of liver injury. In order to
quantify the apoptotic hepatocytes, we used the terminal deoxy-
nucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate
(dUTP) biotin nick end-labeling (TUNEL) method, which labels
the DNA double-strand breaks characteristics of apoptosis.(22) The
assay was carried out by utilizing an in situ apoptosis detection kit
(Wako Pure Chemical, Co. Ltd., Osaka, Japan) according to the
manufacture’s instructions. For quantitative evaluation for apop-
totic index, percent ratios of TUNEL-positive hepatocyte to the
total number of hepatocytes were calculated for each sample in
five random fields (400×).
Western blot analysis. Liver tissue specimens were obtained
and immediately frozen in liquid nitrogen. Frozen liver tissues
were homogenized in lysis buffer containing 10 mM HEPES,
pH 7.9, 150 mM NaCl, 1 mM EDTA, 0.6% NP-40, 0.5 mM
phenylmethylsulfonyl fluoride, 1 μg/ml leupeptin, 1 μg/ml apro-
tinin, 10 μg/ml soybean trypsin inhibitor, and 1 μg/ml pepstatin
on ice. The homogenates were sonicated and centrifuged at
5,000 rpm to remove cellular debris. The protein concentration
was determined using the BCA Protein Assay kit (Pierce
Chemical Co. Rockford, IL). Liver lysate protein (20 μg) was
subjected to the XV PANTERA system (DRC, Tokyo, Japan).
Samples were electrophoresed in a precast 7.5–15% gradient XV
PANTERA Gel, and transferred to a polyvinylidene difluoride
membrane. Nonspecific binding sites were blocked with TBS
(40 mM Tris, pH 7.6, 300 mM NaCl) with 0.1% Tween 20
containing 0.5% nonfat dry milk, for 1 h at room temperature.
The membranes were then incubated with antibodies to rabbit
polyclonal anti-mouse actin, caspase 9 (Santa Cruz Biotechnology,
Santa Cruz, CA), caspase 3, or caspase 8 (CHEMICON Inter-
national Inc., Temecula, CA) in TBST. After five washes in TBST,
membranes were incubated with horseradish peroxidase-conjugated
donkey anti-rabbit IgG. Immunoreactive proteins were detected
by enhanced chemiluminescence according to the manufacturer’s
instructions, and were quantitated with image analysis software
(NIH image, Bethesda, MD). The quantification data evaluated
by the band-intensity ratio of cleaved caspase 3, caspase 8, and
caspase 9 were normalized to that of actin. Results are representa-
tive of two independent experiments.
Electrophoretic mobility shift assay (EMSA). The nuclear
extracts of liver tissue were prepared as described previously.(23)
The protein concentrations were determined by a bicinchoninic
acid assay with trichloroacetic acid precipitation, using BSA as a
reference standard. Double-stranded NF-κB consensus oligo-
nucleotide (Promega, Madison, WI) was end-labeled with [γ−32P]
ATP (3,000 Ci/mmol, Amersham, Arlington Heights, IL). Binding
reactions containing equal amounts of protein (20 μg) and
35 fmols (~50,000 cpm, Cherenkov counting) of oligonucleotide
were performed for 30 min in binding buffer (4% glycerol, 1 mM
MgCl2, 0.5 mM EDTA, pH 8.0, 0.5 mM dithiothreitol, 50 mM
NaCl, 10 mM Tris, pH 7.6, 50 μg/ml poly (dI￿dC); Pharmacia,
Piscataway, NJ). The reaction volumes were held constant at
15 μl. The reaction products were separated on a 4% poly-
acrylamide gel and analyzed by autoradiography.
Blood and ELISA quantification of tissue proteins. Blood
was obtained by cardiac puncture at the time of sacrifice. Serum
samples were analyzed for alanine aminotransferase (ALT) as an
index of hepatocellular injury, using a diagnostic kit (Wako Pure
Chemical, Japan). Hepatic nitrotyrosine production in the liver
was quantitatively assessed by methods described elsewhere.(23)
Briefly, specimens were obtained and frozen immediately, and
then were homogenized in 10 volumes of homogenization buffer
(10 mM ethylenediaminetetraacetic acid, 2 mM phenylmethyl-
sulfonyl fluoride, 0.1 mg/ml soybean trypsin inhibitor, 1.0 mg/ml
bovine serum albumin, 0.02% sodium azide, and 0.2 μl/ml pro-
tease inhibitor cocktail [1,000 × stock; 1 mg/ml leupeptin, 1 mg/ml
aprotinin, and 1 mg/ml pepstatin]). After incubating for 2 h at 4°C,
the homogenate was centrifuged at 12,500 g for 10 min. Superna-
tant was removed and centrifuged again to obtain clear lysate.
Total protein concentration of each sample was measured by using
a bicinchoninic assay kit, and samples were dispensed for
nitrotyrosine EIA kit (OXIS International Inc., Foster City, CA).
Fig. 1. Time course of hepatocyte apoptosis after reperfusion was
assessed using the TUNEL method. Samples were obtained from WT (A)
and FL (B) mice prior to the operation, at 1 and 4 h after reperfusion in
WT (C) and FL (D) mice. Original magnification ×400. The number of
apoptotic cell was quantitated to yield the apoptotic index (E). I/R:
ischemia for 90 min and reperfusion. The values represent the mean ±
SEM with n = 6 per group. *p<0.05, compared to the WT group.doi: 10.3164/jcbn.10 74
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Protein concentration was calculated per mg total protein.
Statistical analysis. All data were analyzed for statistical
significance using the Mann-Whitney test or were analyzed with a
one-way analysis of variance and individual group means were
then compared with a Student-Newman-Keuls test. All data were
expressed as the mean ± SEM. Overall survival was calculated
using the Kaplan-Meier method, and comparisons were evaluated
using the log rank test. The data were analyzed by using the
SigmaStat 3.0 or SPSS 11.5 software program. A value of p<0.05
was considered to be statistically significant.
Results
Liver apoptosis during ischemia/reperfusion. TUNEL
staining was performed to investigate whether hepatocyte
apoptosis was induced after reperfusion. The number of TUNEL-
positive apoptotic hepatocytes quantified by calculating the
apoptotic index in FL mice increased significantly compared
with that in sham mice 1 h after reperfusion (n = 6, respectively).
This increase was not observed in WT mice. A significant increase
in TUNEL-positive apoptotic cells in FL mice was seen relative to
WT mice 1 and 4 h after reperfusion (Fig. 1). To determine the
precise apoptosis pathway activated during ischemia/reperfusion,
we performed western blot analysis of precursor and cleaved
caspases-3, -8, and -9. In FL mice, cleavage of caspase-3 and -9
was increased more than that in WT mice 1 and 4 h after reperfu-
sion. However, the expression of cleaved caspase-8 did not differ
between the FL and WT mice (Fig. 2).
Expression of peroxynitrite during ischemia/reperfusion.
Since NOS-mediated NO generates the peroxynitrite oxidant,
we examined nitrotyrosine expression by ELISA. Hepatic nitro-
tyrosine expression was significantly increased in FL mice 1 h
after reperfusion, as compared to WT mice (n = 6, respectively;
FL, 16.9 ± 9.3, WT 5.2 ± 2.6 pmol/mg, p<0.05).
Activation of NF κB during ischemia/reperfusion. Since
NF-κB is known to play a role in both inflammatory responses
and anti-apoptosis effects,(11–24) we performed EMSA to determine
whether NF-κB activation was induced by hepatic ischemia/reper-
fusion. After reperfusion, nuclear translocation of NF-κB in WT
mice increased 1 and 4 h after reperfusion, but little NF-κB activa-
tion was observed in FL mice up to 4 h after reperfusion (Fig. 3).
Hepatocellular injury after hepatic ischemia/reperfusion.
To assess the extent of hepatic injury during ischemia/reperfusion,
serum levels of ALT were examined (n = 6, respectively). The
serum ALT levels in the FL mice were significantly increased
relative to the WT mice 1 and 4 h after reperfusion (Fig. 4A). The
histological findings showed that focal hepatic necrosis was
observed in the FL mice 4 h after reperfusion (Fig. 4B–E).
Role of iNOS in apoptosis and liver damage during
ischemia/reperfusion. To determine whether iNOS was in-
volved in liver apoptosis during hepatic ischemia/reperfusion, we
performed TUNEL staining. The number of TUNEL positive
cells, quantified by calculating the apoptotic index, was signifi-
cantly upregulated 4 h after reperfusion in WT and FL mice rela-
tive to sham-operated controls (n = 6, respectively; Fig. 5). There
was significant difference in apoptotic index of WT mice
Fig. 2. (A) Time course of precursor and cleaved caspase 3,  8, and  9 activation in the liver was assessed by western blotting in WT and FL mice.
Samples were obtained from mice undergoing sham operation or ischemia/reperfusion (I/R). To ascertain that there was equal protein loading, the
same samples were probed with anti actin antibody. Each lane represents a sample from an individual animal. The results were quantitated to show
the ratio of each of caspase 3 (B),  8 (C), and  9 (D) to actin as determined by an image analysis of an autoradiogram. The results are representative
of two independent experiments. J. Clin. Biochem. Nutr. | March 2011 | vol. 48 | no. 2 | 145
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administered AG as an iNOS specific inhibitor. Treatment with
AG significantly reduced the number of apoptotic cells in FL mice
relative to treatment with PBS (Fig. 5). To determine whether
iNOS was involved in hepatic ischemia/reperfusion injury, we
examined the serum alanine aminotransferase (ALT) levels
following the administration of AG. In sham-operated controls,
there were no differences in serum ALT levels among WT and FL
mice treated with PBS or AG. One hour after reperfusion, serum
ALT levels were significantly decreased by administration of
AG (56% decrease, p = 0.002) in the WT mice. In the FL mice,
Fig. 3. NF κB activation in whole liver homogenates during hepatic
ischemia/reperfusion. Nuclear extracts from liver tissue were subjected
to EMSA. The results are representative of two separate time course
experiments. Both WT and FL mice underwent either a sham operation
or ischemia for 90 min (I/R).
Fig. 4. (A) Hepatocellular injury as indicated by serum levels of alanine
aminotransferase (ALT). Samples were obtained from mice undergoing
the sham operation or ischemia for 90 min and reperfusion (I/R). Values
represent the mean ± SEM with n = 6 per group. *p<0.05, compared to
the WT group. Histological findings of the liver assessed by hematoxylin
and eosin staining. (B) Sham operated WT group. (C) Sham operated FL
group. (D) WT group 4 h after reperfusion. (E) FL group 4 h after reper 
fusion. Original magnification ×100.
Fig. 5. Hepatocyte apoptosis induced by ischemia/reperfusion assessed
by the TUNEL method. To assess the effect of the iNOS inhibitor on
hepatocyte apoptosis, samples from mice treated with PBS or amino 
guanidine (AG) prior to ischemia for 90 min were examined. Samples
were obtained from (A) sham operated WT, (B) sham operated FL, and
(C) FL mice undergoing 90 min ischemia and 4 h reperfusion (I/R) with
PBS treatment, (D) WT mice undergoing I/R with PBS treatment, (E) FL
mice undergoing I/R with AG treatment. (F) WT mice undergoing I/R
with AG treatment. Original magnification ×200. Arrows indicate
hepatocyte apoptosis. The apoptotic index was also calculated in mice
4 h after reperfusion (G). The data represent the mean ± SEM with n =6
per group. *p<0.05 compared to mice treated with PBS.doi: 10.3164/jcbn.10 74
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administration of AG also attenuated serum ALT levels (20%
decrease, p = 0.025) compared with the FL mice treated with PBS
1 and 4 h after reperfusion (Fig. 6).
Survival after ischemia/reperfusion. To determine whether
apoptosis and subsequent hepatic ischemia/reperfusion injury
may be related to death, we examined the survival of mice after
administration of AG. In sham-operated controls, neither WT nor
FL mice died after treatment with PBS or AG (Fig. 7). None of
WT mice undergoing ischemia for 90 min died during 8 h after
reperfusion. On the other hand, the survival rate in FL mice under-
going ischemia for 90 min after reperfusion was significantly
worse. However, treatment with AG significantly ameliorated
survival after reperfusion in the FL mice (Fig. 7).
Discussion
Liver surgery for steatotic liver poses risks of post-operative
morbidity, mortality, and primary graft nonfunction.(7,8) One of
the possible causes of this event is hepatic ischemia/reperfusion
injury. We herein provide evidence that the steatotic liver is
vulnerable to hepatic ischemia/reperfusion.
We have also demonstrated that the production of reactive
oxygen species is related to this type of injury. In fact, NO derived
from iNOS is harmful because of production of hazardous reactive
oxygen species, such as peroxynitrite.(14) Peroxynitrite concentra-
tions were significantly upregulated in FL mice compared with
WT mice in the current srudy, suggesting that upregulation of
Fig. 6. To assess the effects of the iNOS inhibitor on hepatocellular injury induced by ischemia/reperfusion, samples from mice treated with PBS or
aminoguanidine (AG) were examined. Samples were obtained from the sham operated group (A), at 1 h (B), and at 4 h (C) after reperfusion.
Hepatocellular injury was assessed by serum ALT levels. Values represent the mean ± SEM with n = 6 per group. *p<0.05, compared to mice treated
with PBS.
Fig. 7. Survival after hepatic ischemia for 90 min up to 8 h after reperfusion (I/R). WT and FL mice were treated with either PBS or AG intravenously.
For all groups, n =6 . J. Clin. Biochem. Nutr. | March 2011 | vol. 48 | no. 2 | 147
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reactive oxygen species produced by iNOS may initiate hepato-
cyte apoptosis in the steatotic liver after ischemia/reperfusion.
This was confirmed by the fact that AG administration reduced the
hepatocyte apoptosis, suggesting that the induction of apoptosis is,
at least in part, attributable to upregulation of iNOS.
The activation of cleaved caspase 8 did not differ between the
WT and FL mice, suggesting that death signaling is unlikely to
play a role in augmenting apoptosis in the steatotic liver. However,
the activation of cleaved caspase 9 was prominent in the initial
phase of reperfusion, and cleaved caspase 3 was activated in the
steatotic liver, thus suggesting that the mitochondrial permeability
transition plays an important role in apoptosis associated with
steatotic liver ischemia/reperfusion injury. This pathway has been
known to occur in hepatocytes, and to induce apoptosis more
rapidly than type 1 pathway.(19) Immunohistochemistry revealed
iNOS expression in hepatocytes, especially in the periportal area
(personal observation). It has also been demonstrated that
periportal hepatocytes are vulnerable to hypoxia-reoxygenation
and that Kupffer cells in periportal areas engulf apoptotic cells,
thus resulting in the release of reactive oxygen species.(25,26) Taken
together, the early induction of hepatocyte apoptosis was signifi-
cantly observed after reperfusion in the steatotic liver.
In general, the role of NF-κB during hepatic ischemia/reperfu-
sion injury has been considered proinflammatory. Previous studies
have shown that the therapeutic modalities which reduce inflam-
matory injury after ischemia/reperfusion, also reduce NF-κB
activation.(11) On the other hand, data from other models of liver
injury have suggested that hepatocyte activation of NF-κB is
associated with its anti-apoptotic effects.(24,27) In the current study,
NF-κB activation in whole livers (which is largely representative
of hepatocytes) was decreased in steatotic livers after hepatic
ischemia/reperfusion, as demonstrated by EMSA. The steatotic
liver after reperfusion was vulnerable to hepatocyte apoptosis,
which may be associated with decreased NF-κB-related anti-
apoptotic properties.
The steatotic liver is known to have low ATP levels after hepatic
ischemia/reperfusion.(28,29) Our previous studies have demonstrated
that cellular apoptosis consumes a large amount of nicotinamide
adenine dinucleotide (NAD+), and to resynthesize NAD+, resulting
in a decrease in ATP levels.(30) Combination with hepatocyte
apoptosis and ATP depletion changes the cellular response to
secondary oncotic necrosis.(31) These findings suggest that hepato-
cyte apoptosis in conjunction with a decrease in ATP levels causes
secondary oncotic necrosis, leading to significant liver injury. This
is consistent with our observation that the serum ALT levels were
greatest in the steatotic liver, which resulted in severe liver
damage and lower survival in the late phase of reperfusion in the
steatotic liver. Treatment with AG improved the survival of FL
mice after reperfusion, suggesting that iNOS-related hepatocyte
apoptosis seems to initiate hepatic ischemia/reperfusion injury
in the steatotic liver. However, the current study demonstrated
that the reduction in liver injury as defined by serum ALT levels
under the blockade of iNOS is modest, thus suggesting that other
mechanism might be related to this type of injury.
In conclusion, our data suggest that the steatotic liver is
vulnerable to ischemia/reperfusion injury due to hepatocyte
apoptosis associated with the early upregulation of iNOS-related
peroxinitrite, which thus leads to subsequent oncotic necrosis.
The present data are considered to expand our knowledge of
steatosis and therefore clinically applicable for patients with
ischemia/reperfusion injury during liver surgery for steatotic liver.
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NF-κB nuclear factor-kappa B
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